{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1186/S40345-019-0156-X",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.tools/R-LiNK",
      "@type": "sc:SoftwareApplication",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3384"
        },
        {
          "@id": "edam:topic_3419"
        },
        {
          "@id": "edam:topic_0622"
        }
      ],
      "sc:citation": [
        "pmcid:PMC6760458",
        {
          "@id": "https://doi.org/10.1186/S40345-019-0156-X"
        },
        "pubmed:31552554"
      ],
      "sc:description": "> CORRECT NAME OF TOOL COULD ALSO BE 'Response Lithium Network' | Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders | Optimizing response to lithium treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative | R-Link is a multinational study funded by the European Unionâ€™s Horizon 2020 Research and Innovation programme. R-Link involves eight European countries including France, United Kingdom, Denmark, Spain, Norway, Sweden, Germany and Italy",
      "sc:name": "R-LiNK",
      "sc:url": "http://www.r-link.eu.com/"
    }
  ]
}